Onco
MDPI AG · Switzerland
Aims & Scope
Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: targeted therapy, oncogenes, oncoproteins, tumor suppressors, signal transduction, cellular processes
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Frequently asked questions about Onco
Is Onco a predatory journal?
PubScope has no integrity flags on record for Onco: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 60/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Onco?
Onco is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.32.
Is Onco indexed in Scopus and Web of Science?
Onco is indexed in Scopus, DOAJ.
What is the aims and scope of Onco?
Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: targeted therapy, oncogenes, oncoproteins, tumor suppressors, signal transduction, cellular processes
How much does it cost to publish in Onco?
Onco charges an article processing charge (APC) of about CHF 1,000 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref